In the European HIFMECH study in which patients from two high-risk CAD centers in northern Europe and two low-risk CAD centers in southern Europe were analyzed, the association between IL6 promoter polymorphisms (-572G>C and -174G>C) with circulating levels of inflammatory markers and the risk of MI. This evidence concerns the gene IL6 and coronary artery disorder.